What is a platform investment thesis in healthcare PE?
A platform investment thesis is the PE firm's plan for how a first acquired practice will grow into a multi-location roll-up through add-on acquisitions, built around growing EBITDA substantially over a hold period that now runs to a 6.0-year median. We have not found a published figure for how much EBITDA growth platforms target, so treat any specific multiple of growth as a negotiating claim rather than a benchmark.
Want this answered for your own clinic?
Definition
A platform investment thesis is the written strategic rationale a private equity firm builds around an initial acquisition, laying out the add-on pipeline, operational improvements, and exit plan that justify the platform multiple.
The detail
Platform deals are priced at a premium because the buyer is paying for the foundation of a regional or national roll-up as well as for the practice itself. A thesis usually covers four things. First, the add-on map: which sub-markets, how many clinics to buy, at what average multiple and EBITDA size. Second, operational improvements: centralizing billing, procurement, credentialing, and real estate to lift margins. Third, clinical expansion: adding ancillary services (imaging, specialty lines, telehealth) that were previously out of reach for a single practice. Fourth, the exit: who buys next (larger PE, strategic acquirer, IPO), at what multiple, with what timing. Sellers who become the platform often keep a stake through rollover equity, so they share in the gain if the thesis works. It does not always work.
The median holding period for private-equity-backed portfolio companies has reached 6.0 years, the longest since Private Equity Info began tracking it, which is the horizon a platform thesis has to play out over.
What this means for clinic owners
From Sorso
If a PE firm is pitching you as a platform, the price they offer is a discount against where they think the exit multiple lands at the end of the hold period. Understand their thesis before you sign, because your rollover equity is worth whatever the next buyer thinks of their execution, not what the current buyer thinks of yours.
Talk it through
Want Stan to look at this for your clinic?
Stan Sukhinin, CFA, founded Sorso in 2020: a fractional CFO and accounting firm for outpatient clinics across the US, with accounting from $2,000 a month and fractional CFO from $4,000. Book a free 30-minute call, bring the question and, if you have it, last month's P&L, and he will tell you what he would check first.
Continue with Sorso
How clinic owners typically work with us after a question like this
Fractional CFO
Strategic CFO for $3M–$50M clinics
Forecasts, location-level P&L, exit prep. Starts at $4,000/mo.
Explore Fractional CFO →Accounting
Healthcare-specialist accounting
Books done right by people who understand clinic finance. Starts at $2,000/mo.
Explore Accounting →Free Assessment
See where your clinic stands
4-minute, 15-question diagnostic. Personalized scorecard emailed to you.
Take the Free Assessment →Related questions
How do PE firms value medical practices?
Private equity firms value a medical practice as a multiple of its trailing-twelve-month adjusted EBITDA, and the multiple rises with scale. Published ladders run from 2.5–4x for a single owner-operated physical therapy clinic (Breakwater M&A) to 10x–20x for large primary care platforms (Scope Research), and payer mix, growth and owner dependence move a practice within its band.
What is the difference between platform and add-on multiples?
Platform acquisitions trade at higher EBITDA multiples than add-ons because the buyer is paying for scale, management and a base to acquire from, while an add-on brings its earnings into a platform that already has those things. In dental, FOCUS Investment Banking puts platform investments at 9–11× EBITDA and add-on acquisitions at 5–8×.
Should I sell my practice to private equity?
Selling to private equity makes sense if you want partial liquidity, want to grow with capital and infrastructure, and are willing to operate as a partner rather than sole owner; it is wrong if you want full retirement or full operational autonomy.
What is rollover equity in a practice sale?
Rollover equity is the portion of sale proceeds that the selling owner retains as equity in the buyer's platform, generally 10 to 40 percent of the practice's total enterprise value in physician deals according to Foley & Lardner, creating a second liquidity event when the platform is later sold.
Founder of Sorso and a CFA charterholder. Before Sorso, Stan spent 19 years in corporate finance at institutions including UniCredit and Société Générale — managing a $450M loan portfolio and making senior partner at a major mezzanine lender by 29 — then built a fractional CFO firm exclusively for outpatient healthcare clinics.
Want to see how your practice measures up?
Take the 4-minute financial assessment. It is free, and it will show you where your practice is leaking money.